Investment Rating - The report indicates a moderate growth in total store sales, with a rating of low single-digit growth (LSD) for the latest quad-week [1]. Core Insights - Total store sales increased by 2% in the latest quad-week, driven primarily by the Dairy category, while Frozen and Alcohol categories experienced declines [1]. - The report highlights a mixed performance in the Beverages sector, with non-alcoholic categories showing stable trends for carbonated soft drinks (CSDs), sparkling water, and sports drinks, while ready-to-drink (RTD) tea and coffee saw accelerated sales growth [2]. - In the Tobacco sector, sales growth trends remained stable for the overall cigarette category, although specific companies like IMB experienced a deceleration in growth [3]. Summary by Category HPC (Household and Personal Care) - HPC sales growth improved to 2.0% from 1.5% in the previous month, primarily driven by higher pricing, despite lower volume growth [10]. - KMB continued to show robust sales growth, while PG and CL experienced slight moderation in growth [10]. - KVUE and CHD saw improvements in sales growth, with KVUE benefiting from higher volume growth and CHD from improved volume trends [10]. Beverages - Non-alcoholic beverage sales trends were mixed, with stable trends for CSDs and sparkling water, while RTD tea and coffee saw accelerated growth [2]. - Alcoholic beverage sales trends modestly decelerated across all categories, with some companies like BF showing improved trends [2]. Tobacco - Overall sales growth in the cigarette category remained stable, but IMB saw a deceleration in growth trends [3]. Food - Sales in the Food category decelerated in the latest quad-week, contrasting with the growth seen in HPC [1]. Private Label - Private label's dollar share growth remained modest at the total store level, with slight fluctuations across various categories [9].

Financial Data and Key Metrics Changes - The company reported first quarter sales of $2.1 billion, reflecting a 4.3% increase on an organic basis and a 2.6% increase on a reported basis [25] - Adjusted earnings per share (EPS) for the quarter was $1.34, exceeding expectations [31] - Gross margins were 55.6% of sales, slightly ahead of expectations but down 260 basis points compared to the prior year [29] Business Segment Data and Key Metrics Changes - The MedSurg segment generated $1.2 billion in sales, an increase of 6% on an organic basis, driven by strong performance in Infection Prevention and Surgical Solutions [27] - The Dental Solutions segment reported $328 million in revenue, a 0.4% increase on an organic basis, benefiting from new product launches despite market challenges [28] - The Health Information Systems (HIS) segment contributed $329 million in revenue, a 3.9% organic growth, supported by strong customer retention [28] - The Purification and Filtration segment delivered $242 million in sales, a 2.2% organic growth, led by bioprocessing filtration [28] Market Data and Key Metrics Changes - The company experienced a favorable foreign exchange impact, with currency now estimated to have a neutral effect on sales growth for the year, compared to a previous estimate of a 150 basis point headwind [34] - The overall market volumes remain challenged, particularly in the Dental segment, but the company is seeing resilience in its core restorative areas [28][84] Company Strategy and Development Direction - The company is committed to investing in key areas to support sustainable growth and margin improvement, focusing on five growth driver areas [12][21] - The ongoing separation process is on track, with over 30% of transition service agreements exited and significant progress in ERP deployments planned for the year [24] - The company anticipates completing the divestiture of the Purification and Filtration business by the end of 2025, which will allow for tuck-in M&A opportunities [19][21] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the headwinds from tariffs but expressed confidence in managing these challenges through mitigation strategies and strong business momentum [8][34] - The company raised its full-year organic sales growth guidance to a range of 1.5% to 2.5%, reflecting positive volume-driven performance across business segments [32] - Management emphasized the importance of delivering for customers and maintaining focus on long-term value creation despite short-term challenges [11][38] Other Important Information - The company has made cumulative repayments of $400 million on its $1.5 billion prepayable term loans, ending the quarter with $534 million in cash and equivalents [31] - Free cash flow for Q1 declined by $80 million, consistent with expectations due to planned payments and one-time separation costs [31] Q&A Session Summary Question: Confidence in underlying growth rate - Management expressed confidence in the 2.5% underlying growth rate, attributing it to strong commercial execution and analytics from distributor partners [40][42] Question: Quarterly cadence and impact of tariffs - Management clarified that tariffs primarily impact the bottom line, with expectations for most order timing impacts to be realized in Q3 [48][49] Question: Top line drivers in MedSurg - Management highlighted improvements in commercial execution and new product launches as key drivers for growth in the MedSurg segment [60][62] Question: Tariff impact and mitigation efforts - Management discussed ongoing mitigation strategies, including optimizing inventory and exploring selective pricing strategies to offset tariff impacts [68][72] Question: Performance in Dental segment relative to market - Management indicated that the Dental segment performed well relative to the market, supported by new product innovations [84]

Financial Data and Key Metrics Changes - The company experienced a 31% decline in sales during the first half of 2024, which improved to a year-on-year decline of 17% in the second half of the year [4]. Business Line Data and Key Metrics Changes - The construction sector faced significant challenges in 2024, impacting cement consumption due to key economic variables and the suspension of many public works projects [5]. Market Data and Key Metrics Changes - The overall industry saw a decline in volumes by 24% to 25% in the previous year, but the company anticipates a two-digit year-on-year increase in volumes for 2025 if the last part of 2024's volumes are maintained [13][15]. Company Strategy and Development Direction - The company is focusing on maintaining pricing dynamics similar to the previous years, with expectations that prices will align with inflation, assuming inflation remains above the devaluation of the peso [9]. Management Comments on Operating Environment and Future Outlook - Management acknowledged the challenging environment in 2024 but expressed optimism for 2025, citing potential private projects that may commence soon [15]. Other Important Information - The Board decided not to pay dividends in 2024 due to the drop in volumes and uncertainty in the market, contrasting with the dividend payments made in 2022 and 2023 [18]. Q&A Session Summary Question: Pricing strategy for 2025 - Management indicated that pricing dynamics in 2025 would likely mirror those of the last couple of years, with a potential deceleration of inflation allowing for more spaced price increments [9]. Question: Volume expectations for 2025 - The company expects a two-digit year-on-year increase in volumes for 2025, contingent on maintaining the volumes from the latter part of 2024 [15]. Question: Dividend expectations for 2025 - The Board did not move forward with dividends in 2024 due to market conditions, and the decision for 2025 is still under analysis [18]. Question: Cost structure and margin opportunities for 2025 - Management noted improvements in energy inputs and indicated that they are assessing their cost structure for potential margin increases [24]. Question: CapEx guidance for 2025 - The company plans to focus on maintenance CapEx for 2025, estimating maintenance costs between $55 million and $60 million [26]. Question: Remaining CapEx for specific projects - The remaining CapEx for the 25-kilogram project is approximately $22 million [31].